- Home
- ARVN vs RPAY Comparison
ARVN vs RPAY Comparison
Compare ARVN & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- RPAY
- Stock Information
- Founded
- ARVN 2015
- RPAY 2006
- Country
- ARVN United States
- RPAY United States
- Employees
- ARVN N/A
- RPAY N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- RPAY Business Services
- Sector
- ARVN Health Care
- RPAY Consumer Discretionary
- Exchange
- ARVN Nasdaq
- RPAY Nasdaq
- Market Cap
- ARVN 456.2M
- RPAY 473.8M
- IPO Year
- ARVN 2018
- RPAY N/A
- Fundamental
- Price
- ARVN $7.61
- RPAY $5.65
- Analyst Decision
- ARVN Buy
- RPAY Buy
- Analyst Count
- ARVN 22
- RPAY 9
- Target Price
- ARVN $20.02
- RPAY $7.22
- AVG Volume (30 Days)
- ARVN 1.3M
- RPAY 688.4K
- Earning Date
- ARVN 10-29-2025
- RPAY 11-11-2025
- Dividend Yield
- ARVN N/A
- RPAY N/A
- EPS Growth
- ARVN N/A
- RPAY N/A
- EPS
- ARVN N/A
- RPAY N/A
- Revenue
- ARVN $372,800,000.00
- RPAY $310,367,000.00
- Revenue This Year
- ARVN $1.61
- RPAY N/A
- Revenue Next Year
- ARVN N/A
- RPAY $9.47
- P/E Ratio
- ARVN N/A
- RPAY N/A
- Revenue Growth
- ARVN 299.57
- RPAY 1.45
- 52 Week Low
- ARVN $5.90
- RPAY $3.59
- 52 Week High
- ARVN $29.61
- RPAY $9.75
- Technical
- Relative Strength Index (RSI)
- ARVN 49.90
- RPAY 50.25
- Support Level
- ARVN $7.58
- RPAY $5.53
- Resistance Level
- ARVN $7.89
- RPAY $5.96
- Average True Range (ATR)
- ARVN 0.37
- RPAY 0.22
- MACD
- ARVN -0.03
- RPAY -0.04
- Stochastic Oscillator
- ARVN 18.42
- RPAY 25.69
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.